4Shiiki H,Saito T,Nishitani Y,et al. Prognosis and risk factorsfor idiopathic membranous nephropathy with nephroticsyndrome in Japan[J]. Kidney Int,2004,65(4) : 1400-1407.
5Ponticelli C,Altieri P, Scolari F,et al. A randomized studycomparing methylprednisolone plus chlorambucil versusmethylprednisolone plus cyclo-phosphamide in idiopathicmembranous nephropathy[J]. J Am Soc Nephrol,1998,9(3):444-450.
6Jha V,Ganguli A,Saha TK,et al. A randomized controlled trialof steroids and cyclophosphamide in adults with nephroticsyndrome caused by idiopathic membranous nephropathy[J], JAm Soc Nephrol,2007,18(6) :1899-1904.
7Yuan J . Fang W, Zhang W, et al. Treatment of nephroticidiopathic membranous nephropathy with monthly i. v. pulsecyclophosphamide and oral steroids: a single center, sretrospective study [J]. Nephrology ( Carlton ),2011,16(4):440-445.
8Quaglia M, Stratta P. Idiopathic membranous nephropathymanagement strategies[J], Drugs,2009,69( 10) : 1303-1317.
9Ponticelli C,Zucchelli P, Passerini P. Therapy of idiopathicmembranous nephropathy[J]. Springer Semin Immunopathol,1987,9(4):431-440.
